Archer® Clinical Services

Accelerating Personalized Medicine

Providing CLIA/CAP next-generation sequencing (NGS) services and testing solutions to help healthcare providers develop and deliver precision and personalized medicine.

ArcherDX, Inc. Clinical Sequencing Services is performed in the ArcherDX CLIA (Clinical Laboratory Improvements Amendment)-certified and CAP (College of American Pathologists)-accredited Clinical Services Laboratory. The ArcherDX sequence information is generated by licensed personnel using an analytically validated process. Consistent with laboratory developed tests, it has not been cleared or approved by the U.S. Food and Drug Administration.

This sequencing information can be analyzed to potentially aid physicians in helping support therapeutic decision making. Patients will not receive medical results, or a diagnosis, or a recommendation for treatment from ArcherDX. If any questions or concerns arise about what is learned through this sequencing information, patients should contact their treating physician or a genetic counselor. Currently ArcherDX does not accept orders for ArcherDX Clinical Sequencing Services from New York.

Set Up a Consultation Now

Scientist Looking at Microscope
Clinical Sequencing Services

Inherited Disease: Newborn genetic testing, carrier screening, confirmatory testing

Oncology: Tumor profiling

Research Support Services

Analyte Extraction: DNA, RNA, TNA

Library Preparation

Next-generation sequencing (NGS): Illumina®

Bioinformatics Support

Validation Support

This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy.

We won’t track your information when you visit our site. But in order to comply with your preferences, we’ll have to use just one tiny cookie so that you’re not asked to make this choice again.